HF
RXII

Hoxton Financial’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Hoxton Financial’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$68K Hold
50,000
– – 0.04% 134
2015
Q4 		$74K Hold
50,000
– – 0.04% 113
2015
Q3 		$79K Buy
50,000
+30,000
+150% +$47.4K 0.04% 109
2015
Q2 		$34K Hold
20,000
– – 0.01% 157
2015
Q1 		$28K Buy
+20,000
New +$28K 0.01% 169

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Hoxton Financial's RXII Position: Q1 2016 in Review

Hoxton Financial held its GALENA BIOPHARMA INC COM (RXII) position steady in Q1 2016 at 50,000 shares worth $68K. The position accounts for 0.04% of the portfolio, ranked #134.

Hoxton Financial first reported a position in RXII in Q1 2015 and has held it in 5 quarters since. The position peaked at $79K in Q3 2015. 71 funds tracked by Wall St. Rank hold RXII as of Q1 2016.

  • Hoxton Financial held 50,000 shares of GALENA BIOPHARMA INC COM worth $68K as of Q1 2016.
  • Hoxton Financial left its GALENA BIOPHARMA INC COM share count unchanged in Q1 2016.
  • GALENA BIOPHARMA INC COM made up 0.04% of Hoxton Financial's portfolio in Q1 2016, its #134 holding.
  • Hoxton Financial first reported a position in GALENA BIOPHARMA INC COM in Q1 2015 and has held it in 5 quarters since.
  • Hoxton Financial's GALENA BIOPHARMA INC COM position peaked at $79K in Q3 2015.
  • 71 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.